US biotech Gilead Sciences (Nasdaq: GILD) has agreed a global licensing deal worth up to $1.5 billion with China’s Genhouse Bio for its synthetic lethal cancer candidate GH31.

Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended ...

Shares of US drug developer Upstream Bio plunged 35% to $9.38 this morning on the release of new data on its lead candidate ...

Driving Innovation and Sustainability in the Sanitary Napkin Market with Advanced Manufacturing Solutions CALIFORNIA, ...

Connor Senger, 30, has been a full-time assistant with the Arizona Cardinals the past three seasons and was a pass game ...

That’s because the trunk is highly sensitive when it comes to sensing touch. Scientists have determined that the whiskers ...

Hair extensions used primarily by Black women contain a “shocking” range of dangerous chemicals, including breast carcinogens, new research shows.

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- The shape moulding machine industry ...

The opening of La Maison Orveda Bangkok marks a significant new chapter in the celebrated beauty brand's global expansion.

That intervention arrived in the form of the Godrej NX PRO Luxe Digi + Bio 30L home locker, a steel monolith weighing 20.9 ...

As of Wednesday, February 11, Parsons Corporation’s PSN share price has dipped by 9.78%, which has investors questioning if this is right time to buy.

Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...